BOSTON (AP) — BOSTON (AP) — Aktis Oncology Inc. (AKTS) on Thursday reported a loss of $29.9 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of 54 cents. The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment...